Showing results (201-210 of 377) with videos related to
Sort By:
Pageof 38
Oncology Reports|December 6, 2005
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activitiesHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.International Journal of Molecular Medicine|October 4, 2007
Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in ratsKiyoshi Asada, Hitoshi Yoshiji, Ryuichi Noguchi, et al.Oncotarget|July 10, 2018
Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis modelKenichiro Seki, Mitsuteru Kitade, Norihisa Nishimura, et al.Oncology Reports|January 5, 2007
Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activitiesKoji Yanase, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.Journal of Gastroenterology|March 26, 2009
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic ratsHitoshi Yoshiji, Ryuichi Noguchi, Mitsuteru Kitade, et al.Experimental and Therapeutic Medicine|December 2, 2020
Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascitesHideto Kawaratani, Kei Moriya, Tadashi Namisaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 17, 2019
Blocking development of liver fibrosis augments hepatic progenitor cell-derived liver regeneration in a mouse chronic liver injury modelMitsuteru Kitade, Kosuke Kaji, Norihisa Nishimura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2020
Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center studyHideto Kawaratani, Yuki Tsuji, Koji Ishida, et al.Journal of Clinical Medicine|May 20, 2020
Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver FailureHiroaki Takaya, Tadashi Namisaki, Shinya Sato, et al.Journal of Gastroenterology|July 1, 2017
Response criteria of tolvaptan for the treatment of hepatic edemaYasunari Hiramine, Haruki Uojima, Hiroyuki Nakanishi, et al.Pageof 38